← 홈

전체 프로그램

ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-14 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,526개
CGTBiologicstaleChinese PLA General HospitalPhase 1

GoFast CD19 CAR T Cells (GoFast CD19 CAR T Cells)

Relapsed or Refractory Large B-cell Lymphoma · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
AntibodystaleHookipa Biotech GmbHPhase 2

pembrolizumab (Keytruda, HB-202 / HB-201 alternating intravenous administration + pembrolizumab.)

HPV-Related Squamous Cell Carcinoma · HPV-Related Squamous Cell Carcinoma

#HPV-RelatedSquamousCellCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
ADCBiologicstaleCSPC Megalith Biopharmaceutical…Phase 2

HB1901 (HB1901)

Advanced Breast Cancer · Advanced Breast Cancer

#AdvancedBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
CGTBiologicstaleHadassah Medical OrganizationPhase 2

HBI 0201-ESO TCRT (HBI 0201-ESO TCRT)

Sarcoma, Synovial; Sarcoma,Soft Tissue · Sarcoma, Synovial

#SarcomaSynovial#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
AntibodystaleHarbour BioMed (Guangzhou) Co. …Phase 1

pembrolizumab (Keytruda, HBM4003 and pembrolizumab)

Solid Tumor · Solid Tumor

#SolidTumor#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
ADCBiologicstaleHangzhou Zhongmei Huadong Pharm…Phase 1

HDM2024 (HDM2024)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 1

HDMP + rituximab as a means of debulking prior to initiating venetoclax. (HDMP + rituximab as a means of debulking prior to initiating venetoclax.)

Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · Chronic Lymphocytic Leukemia or Small Ly

#ChronicLymphocyticLeukemiaorSmal#Antibody#Phase1#항체#면역항체+2
효능 ORR 1%임상시험 1상태 RECRUITING
CGTBiologicstaleFuda Cancer Hospital, GuangzhouPhase 2

HER-2-targeting CAR T Cells infusion (HER-2-targeting CAR T Cells infusion)

Breast Cancer · Breast Cancer

#BreastCancer#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 DISCONTINUED
CGTBiologicstaleBaylor College of MedicinePhase 1

HER.CAR CMV-specific CTLs (HER.CAR CMV-specific CTLs)

Glioblastoma Multiforme (GBM) · Glioblastoma Multiforme (GBM)

#GlioblastomaMultiformeGBM#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
AntibodystaleUniversity of VirginiaPhase 2

pembrolizumab (Keytruda, HER2 BATs with Pembrolizumab)

Metastatic Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
CGTBiologicstaleChildren's Oncology GroupPhase 1

HER2 Specific CAR T Cell (HER2 Specific CAR T Cell)

Ependymoma · HER2

#HER2#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstalesu haichuanPreclinical

HER2-E-CART cells (HER2-E-CART cells)

Solid Tumor · HER2

#HER2#CGT#Preclinical#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleSeattle Children's HospitalPhase 1

HER2-specific chimeric antigen receptor (CAR, HER2-specific chimeric antigen receptor, HER2-specific chimeric antigen receptor (CAR) T cell)

Central Nervous System Tumor, Pediatric; Glioma · HER2

#HER2#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 1상태 RECRUITING
ADCBiologicstaleNovartis PharmaceuticalsPhase 1

HKT288 (HKT288)

Epithelial Ovarian Cancer; Renal Cell Carcinoma · Epithelial Ovarian Cancer

#EpithelialOvarianCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 DISCONTINUED
CGTBiologicstaleEver Supreme Bio Technology Co.…Phase 2

HLA-G-CAR.BiTE allogeneic γδ T cells (HLA-G-CAR.BiTE allogeneic γδ T cells)

Solid Tumor · Solid Tumor

#SolidTumor#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
ADCBiologicstaleShanghai Henlius BiotechPhase 1

HLX42 (HLX42)

Solid Tumor and NSCLC · Solid Tumor and NSCLC

#SolidTumorandNSCLC#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleShanghai Henlius BiotechPhase 2

HLX43 DOSE1 IN 1L TNBC (HLX43 DOSE1 IN 1L TNBC)

Breast Cancer (Triple Negative Breast Cancer (TNBC)) · Breast Cancer (Triple Negative Breast Ca

#BreastCancerTripleNegativeBreast#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleShanghai Henlius BiotechPhase 1

HLX48 (HLX48)

Advanced/Metastatic Solid Tumors · Advanced/Metastatic Solid Tumors

#AdvancedMetastaticSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleShanghai Henlius BiotechPhase 3

HLX87+HX22 (HLX87+HX22)

HER2 + Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleHanmi Pharmaceutical Company Li…Phase 1

HM95573, cetuximab (HM95573, cetuximab)

Locally Advanced Solid Tumor; Metastatic Solid Tumor · Locally Advanced Solid Tumor

#LocallyAdvancedSolidTumor#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE

119 / 177 페이지

← 이전다음 →